BUB: Permanent FDA approval secures U.S. market access and unlocks new growth and innovation opportunities
Permanent FDA authorization for three SKUs enables accelerated U.S. growth, validates the supply chain, and supports expansion into premium infant formula segments. The company now holds a strong national presence, is pursuing contract manufacturing, and plans further brand and distribution investm…